Natalizumab (Tysabri) Pharmacokinetic ELISA: An Advanced Analytical Tool
Introduction Natalizumab (Tysabri) is a monoclonal antibody used in the treatment of multiple sclerosis (MS) and Crohn’s disease. Monitoring its pharmacokinetics is crucial for optimizing therapeutic efficacy and minimizing adverse effects. The Natalizumab (Tysabri) Pharmacokinetic ELISA offers a sensitive and specific method for quantifying drug levels in biological samples, providing critical data for personalized treatment
Natalizumab (Tysabri) Pharmacokinetic ELISA: An Advanced Analytical Tool Read More »





